Literature DB >> 32507058

GRK5 Controls SAP97-Dependent Cardiotoxic β1 Adrenergic Receptor-CaMKII Signaling in Heart Failure.

Bing Xu1,2, Minghui Li2,3, Ying Wang2, Meimi Zhao2, Stefano Morotti2, Qian Shi2, Qingtong Wang2,4, Federica Barbagallo2, Jian-Peng Teoh2, Gopireddy R Reddy2, Elizabeth F Bayne5, Yongming Liu2,6, Ao Shen2,7, Jose L Puglisi2, Ying Ge5, Ji Li8, Eleonora Grandi2, Madeline Nieves-Cintron2, Yang K Xiang1,2.   

Abstract

RATIONALE: Cardiotoxic β1 adrenergic receptor (β1AR)-CaMKII (calmodulin-dependent kinase II) signaling is a major and critical feature associated with development of heart failure. SAP97 (synapse-associated protein 97) is a multifunctional scaffold protein that binds directly to the C-terminus of β1AR and organizes a receptor signalosome.
OBJECTIVE: We aim to elucidate the dynamics of β1AR-SAP97 signalosome and its potential role in chronic cardiotoxic β1AR-CaMKII signaling that contributes to development of heart failure. METHODS AND
RESULTS: The integrity of cardiac β1AR-SAP97 complex was examined in heart failure. Cardiac-specific deletion of SAP97 was developed to examine β1AR signaling in aging mice, after chronic adrenergic stimulation, and in pressure overload hypertrophic heart failure. We show that the β1AR-SAP97 signaling complex is reduced in heart failure. Cardiac-specific deletion of SAP97 yields an aging-dependent cardiomyopathy and exacerbates cardiac dysfunction induced by chronic adrenergic stimulation and pressure overload, which are associated with elevated CaMKII activity. Loss of SAP97 promotes PKA (protein kinase A)-dependent association of β1AR with arrestin2 and CaMKII and turns on an Epac (exchange protein directly activated by cAMP)-dependent activation of CaMKII, which drives detrimental functional and structural remodeling in myocardium. Moreover, we have identified that GRK5 (G-protein receptor kinase-5) is necessary to promote agonist-induced dissociation of SAP97 from β1AR. Cardiac deletion of GRK5 prevents adrenergic-induced dissociation of β1AR-SAP97 complex and increases in CaMKII activity in hearts.
CONCLUSIONS: These data reveal a critical role of SAP97 in maintaining the integrity of cardiac β1AR signaling and a detrimental cardiac GRK5-CaMKII axis that can be potentially targeted in heart failure therapy. Graphical Abstract: A graphical abstract is available for this article.

Entities:  

Keywords:  calmodulin; heart failure; myocardium; myocyte, cardiac; signaling pathways

Mesh:

Substances:

Year:  2020        PMID: 32507058      PMCID: PMC7484403          DOI: 10.1161/CIRCRESAHA.119.316319

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  40 in total

1.  Inhibiting Insulin-Mediated β2-Adrenergic Receptor Activation Prevents Diabetes-Associated Cardiac Dysfunction.

Authors:  Qingtong Wang; Yongming Liu; Qin Fu; Bing Xu; Yuan Zhang; Sungjin Kim; Ruensern Tan; Federica Barbagallo; Toni West; Ethan Anderson; Wei Wei; E Dale Abel; Yang K Xiang
Journal:  Circulation       Date:  2016-11-04       Impact factor: 29.690

2.  Cardiac-specific ablation of synapse-associated protein SAP97 in mice decreases potassium currents but not sodium current.

Authors:  Ludovic Gillet; Jean-Sébastien Rougier; Diana Shy; Stephan Sonntag; Nathalie Mougenot; Maria Essers; Doron Shmerling; Elise Balse; Stéphane N Hatem; Hugues Abriel
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

Review 3.  Reversal of cardiac remodeling by modulation of adrenergic receptors: a new frontier in heart failure.

Authors:  Cinzia Perrino; Howard A Rockman
Journal:  Curr Opin Cardiol       Date:  2007-09       Impact factor: 2.161

4.  Genetically Encoded Biosensors Reveal PKA Hyperphosphorylation on the Myofilaments in Rabbit Heart Failure.

Authors:  Federica Barbagallo; Bing Xu; Gopireddy R Reddy; Toni West; Qingtong Wang; Qin Fu; Minghui Li; Qian Shi; Kenneth S Ginsburg; William Ferrier; Andrea M Isidori; Fabio Naro; Hemal H Patel; Julie Bossuyt; Donald Bers; Yang K Xiang
Journal:  Circ Res       Date:  2016-08-30       Impact factor: 17.367

5.  A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII.

Authors:  S Morotti; A G Edwards; A D McCulloch; D M Bers; E Grandi
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

6.  The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes.

Authors:  Yang Xiang; Eric Devic; Brian Kobilka
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

7.  Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways.

Authors:  Antonio Rapacciuolo; Shayela Suvarna; Liza Barki-Harrington; Louis M Luttrell; Mei Cong; Robert J Lefkowitz; Howard A Rockman
Journal:  J Biol Chem       Date:  2003-06-23       Impact factor: 5.157

8.  Organization of beta-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes.

Authors:  Olga G Shcherbakova; Carl M Hurt; Yang Xiang; Mark L Dell'Acqua; Qi Zhang; Richard W Tsien; Brian K Kobilka
Journal:  J Cell Biol       Date:  2007-02-12       Impact factor: 10.539

9.  Visualization of arrestin recruitment by a G-protein-coupled receptor.

Authors:  Arun K Shukla; Gerwin H Westfield; Kunhong Xiao; Rosana I Reis; Li-Yin Huang; Prachi Tripathi-Shukla; Jiang Qian; Sheng Li; Adi Blanc; Austin N Oleskie; Anne M Dosey; Min Su; Cui-Rong Liang; Ling-Ling Gu; Jin-Ming Shan; Xin Chen; Rachel Hanna; Minjung Choi; Xiao Jie Yao; Bjoern U Klink; Alem W Kahsai; Sachdev S Sidhu; Shohei Koide; Pawel A Penczek; Anthony A Kossiakoff; Virgil L Woods; Brian K Kobilka; Georgios Skiniotis; Robert J Lefkowitz
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

10.  GluR1 controls dendrite growth through its binding partner, SAP97.

Authors:  Weiguo Zhou; Lei Zhang; Xiong Guoxiang; Jelena Mojsilovic-Petrovic; Kogo Takamaya; Rita Sattler; Richard Huganir; Robert Kalb
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

View more
  7 in total

Review 1.  Emerging Therapeutic Targets for Heart Failure.

Authors:  Maneesha Sharma; Lokesh Kumar Bhatt
Journal:  Curr Cardiol Rep       Date:  2022-10-04       Impact factor: 3.955

2.  Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function.

Authors:  Ying Wang; Meimi Zhao; Bing Xu; Sherif M F Bahriz; Chaoqun Zhu; Aleksandra Jovanovic; Haibo Ni; Ariel Jacobi; Nina Kaludercic; Fabio Di Lisa; Johannes W Hell; Jean C Shih; Nazareno Paolocci; Yang K Xiang
Journal:  Basic Res Cardiol       Date:  2022-07-17       Impact factor: 12.416

Review 3.  GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.

Authors:  Marion Laudette; Karina Formoso; Frank Lezoualc'h
Journal:  Cells       Date:  2021-01-14       Impact factor: 6.600

4.  The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1.

Authors:  Mani Sadredini; Ravinea Manotheepan; Stephan E Lehnart; Mark E Anderson; Ivar Sjaastad; Mathis K Stokke
Journal:  Physiol Rep       Date:  2021-09

Review 5.  Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.

Authors:  Yunfeng Pan; Jia Liu; Jiahui Ren; Yun Luo; Xiaobo Sun
Journal:  Front Pharmacol       Date:  2022-07-14       Impact factor: 5.988

6.  Probing spatiotemporal PKA activity at the ryanodine receptor and SERCA2a nanodomains in cardomyocytes.

Authors:  Bing Xu; Ying Wang; Sherif M F M Bahriz; Meimi Zhao; Chaoqun Zhu; Yang K Xiang
Journal:  Cell Commun Signal       Date:  2022-09-14       Impact factor: 7.525

7.  Adaptive versus maladaptive cardiac remodelling in response to sustained β-adrenergic stimulation in a new 'ISO on/off model'.

Authors:  Stefanie Maria Werhahn; Julia S Kreusser; Marco Hagenmüller; Jan Beckendorf; Nathalie Diemert; Sophia Hoffmann; Jobst-Hendrik Schultz; Johannes Backs; Matthias Dewenter
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.